Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Kairos Pharma Ltd.Startup |
Active Organization Kairos Pharma Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | Kairos Pharma Ltd.Startup | 15 Mar 2022 |